These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36592052)

  • 1. New insights into the mucosal immune pathogenesis of IgA nephropathy from the perspective of COVID-19 vaccination.
    Ma Y; Huang Y; Xu G
    QJM; 2023 Mar; 116(3):181-195. PubMed ID: 36592052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New-onset IgA nephropathy following COVID-19 vaccination.
    Ma Y; Xu G
    QJM; 2023 Feb; 116(1):26-39. PubMed ID: 35920797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgA nephropathy with glomerular capillary IgA deposition following SARS-CoV-2 mRNA vaccination: a report of three cases.
    Yokote S; Ueda H; Shimizu A; Okabe M; Yamamoto K; Tsuboi N; Yokoo T
    CEN Case Rep; 2022 Nov; 11(4):499-505. PubMed ID: 35562631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Pathogenic Mechanisms of IgA Nephropathy Secondary to COVID-19 mRNA Vaccination.
    Wang L; Mao Z; Zhang L; Shao F
    Kidney Blood Press Res; 2024; 49(1):144-154. PubMed ID: 38301615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal outcomes in IgA nephropathy following inactivated SARS-CoV-2 vaccination.
    Sun K; Shang D; Hao C; Lai L
    Clin Exp Nephrol; 2024 Jan; 28(1):23-30. PubMed ID: 37713044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers and targeted new therapies for IgA nephropathy.
    Coppo R
    Pediatr Nephrol; 2017 May; 32(5):725-731. PubMed ID: 27324471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sibling cases of gross hematuria and newly diagnosed IgA nephropathy following SARS-CoV-2 vaccination.
    Uchiyama Y; Fukasawa H; Ishino Y; Nakagami D; Kaneko M; Yasuda H; Furuya R
    BMC Nephrol; 2022 Jun; 23(1):216. PubMed ID: 35729514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of gut-homing immunoglobulin A+ B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients.
    Sallustio F; Curci C; Chaoul N; Fontò G; Lauriero G; Picerno A; Divella C; Di Leo V; De Angelis M; Ben Mkaddem S; Macchia L; Gallone A; Monteiro RC; Pesce F; Gesualdo L
    Nephrol Dial Transplant; 2021 Feb; 36(3):452-464. PubMed ID: 33200215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenetic and Therapeutic Role of Gut Microbiome in Immunoglobin A Nephropathy.
    Li HB; Zhou JL; Xie PP; Feng YT; Chen Y; Zhang DF; Wang DG; Pan HF
    Curr Pharm Des; 2023; 29(6):468-473. PubMed ID: 36825697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gut-Renal Connection in IgA Nephropathy.
    Coppo R
    Semin Nephrol; 2018 Sep; 38(5):504-512. PubMed ID: 30177022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mucosa-kidney axis in IgA nephropathy.
    Floege J; Feehally J
    Nat Rev Nephrol; 2016 Mar; 12(3):147-56. PubMed ID: 26714580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L; Peng L; Yang D; Chen S; Lan Z; Zhu X; Yuan S; Chen G; Liu Y; Liu H
    Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 mRNA vaccination is associated with IgA nephropathy: an analysis of the Japanese adverse drug event report database.
    Nakao H; Koseki T; Kato K; Yamada S; Tsuboi N; Takahashi K; Mizuno T
    J Pharm Pharm Sci; 2023; 26():11453. PubMed ID: 37456806
    [No Abstract]   [Full Text] [Related]  

  • 14. IgA nephropathy presenting as rapidly progressive glomerulonephritis following first dose of COVID-19 vaccine.
    Niel O; Florescu C
    Pediatr Nephrol; 2022 Feb; 37(2):461-462. PubMed ID: 34786589
    [No Abstract]   [Full Text] [Related]  

  • 15. Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy.
    Tanaka M; Seki G; Someya T; Nagata M; Fujita T
    Clin Dev Immunol; 2011; 2011():470803. PubMed ID: 21318178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Yiqi Yangying Heluo Formula in the Treatment of IgA Nephropathy by Affecting Gd-IgA1 Based on BAFF Molecular Level and T Lymphocyte Immunity.
    Liang Y; Zeng Q; Wang XH; Yan L; Yu RH
    Biomed Res Int; 2023; 2023():5124034. PubMed ID: 36660452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An adolescent girl diagnosed with IgA nephropathy following the first dose of the COVID-19 vaccine.
    Okada M; Kikuchi E; Nagasawa M; Oshiba A; Shimoda M
    CEN Case Rep; 2022 Aug; 11(3):376-379. PubMed ID: 35118635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the mucosal gamma delta T cell receptor V region repertoire in patients with IgA nephropathy.
    Olive C; Allen AC; Harper SJ; Wicks AC; Feehally J; Falk MC
    Kidney Int; 1997 Oct; 52(4):1047-53. PubMed ID: 9328944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the pathogenesis of IgA nephropathy: do toll like receptor 9-B cell activation factor-IgA class switching recombination signaling axis induce IgA hyper-production?
    Liu Y; Liu H; Peng Y; Liu F
    Ren Fail; 2014 Jul; 36(6):970-3. PubMed ID: 24828398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A possible relationship between anti-SARS-CoV-2 vaccination and glomerular diseases: food for thought for the nephrologist].
    Rizzo M; Marino A; Sannino A; Urciuoli V; Capuano I; Pisani A
    G Ital Nefrol; 2022 Apr; 39(2):. PubMed ID: 35470996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.